LOCALLY ADVANCED BREAST CANCER
Authors:
- Gabriel N. HortobagyiGHGabriel N. Hortobagyi
- 1 April 1999
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 13 (2) , 457-472
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.Journal of Clinical Oncology, 1998
- Preoperative chemotherapy induces apoptosis in early breast cancerThe Lancet, 1997
- Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variablesAnnals of Oncology, 1995
- Combined Modality Treatment of Stage III and Inflammatory Breast CancerSurgical Oncology Clinics of North America, 1995
- Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results1995
- Treatment of Locally Advanced Breast Cancer without Mastectomy.Annals of the New York Academy of Sciences, 1993
- Inflammatory Breast CancerAmerican Journal of Clinical Oncology, 1993
- Management of inflammatory carcinoma of the breastAmerican Journal of Clinical Oncology, 1985
- Inflammatory breast carcinoma treated by radical radiotherapyCancer, 1980
- Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancerCancer Chemotherapy and Pharmacology, 1978